Millennium Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$242K Buy
+3,727
New +$258K ﹤0.01% 5470
2023
Q2
– Sell
-4,968
Closed -$204K – 6766
2023
Q1
$204K Sell
4,968
-23,758
-83% -$998K ﹤0.01% 5157
2022
Q4
$1.18M Buy
28,726
+15,080
+111% +$628K ﹤0.01% 4003
2022
Q3
$548K Buy
13,646
+1,359
+11% +$58.1K ﹤0.01% 4885
2022
Q2
$516K Buy
12,287
+5,059
+70% +$212K ﹤0.01% 4926
2022
Q1
$327K Buy
+7,228
New +$318K ﹤0.01% 5467
2021
Q3
– Sell
-11,712
Closed -$606K – 7322
2021
Q2
$606K Buy
+11,712
New +$588K ﹤0.01% 5136
2017
Q4
– Sell
-21,158
Closed -$900K – 4124
2017
Q3
$900K Buy
+21,158
New +$897K ﹤0.01% 2575
2015
Q4
– Sell
-4,958
Closed -$233K – 3815
2015
Q3
$233K Buy
+4,958
New +$299K ﹤0.01% 3046
2015
Q2
– Sell
-29,134
Closed -$1.8M – 3925
2015
Q1
$1.8M Buy
29,134
+19,482
+202% +$1.16M ﹤0.01% 2008
2014
Q4
$521K Buy
+9,652
New +$527K ﹤0.01% 2952

Other funds holding XPH

Millennium Management's XPH Position: Q3 2026 in Review

Millennium Management opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 3,727 shares worth $242K. The stake represents ﹤0.01% of the portfolio and ranks #5470 among its holdings. This is a return to the name: Millennium Management previously reported a position in XPH as recently as Q1 2023.

Millennium Management first reported a position in XPH in Q4 2014 and has held it in 11 quarters since. The position peaked at $1.8M in Q1 2015. 117 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Millennium Management held 3,727 shares of State Street SPDR S&P Pharmaceuticals ETF worth $242K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Millennium Management position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #5470 holding.
  • Millennium Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and has held it in 11 quarters since.
  • Millennium Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1.8M in Q1 2015.
  • 117 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.